Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up
Open Access
- 1 September 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (9) , 1442-1443
- https://doi.org/10.1128/aac.31.9.1442
Abstract
Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily). The poor performance of cefuroxime axetil is explained by variable bioavailability.This publication has 12 references indexed in Scilit:
- Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infectionJournal of Antimicrobial Chemotherapy, 1986
- Single-dose Cefuroxime Axetil in the Treatment of Uncomplicated Gonorrhea: A Controlled TrialSexually Transmitted Diseases, 1985
- Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infectionJournal of Antimicrobial Chemotherapy, 1985
- A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1985
- The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acidJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosingAntimicrobial Agents and Chemotherapy, 1984
- The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after foodJournal of Antimicrobial Chemotherapy, 1984
- Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteersAntimicrobial Agents and Chemotherapy, 1984
- A concise biotyping system for differentiating strains of Escherichia coli.Journal of Clinical Pathology, 1982
- Cefuroxime - A new cephalosporin antibiotic.The Journal of Antibiotics, 1976